Ireland - English - HPRA (Health Products Regulatory Authority)

gensia europe ltd - arbutamine - solution for infusion - 5 microgram/ml

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

gensia europe ltd. - arbutamine 50 µg/ml - solution for infusion - arbutamine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

gensia europe - arbutamine - solution for infusion - arbutamine 50 µg/ml - arbutamine

Canada - English - Health Canada

pharmaceutical partners of canada inc - zinc (zinc sulfate); copper (cupric sulfate); manganese (manganese sulfate); chromium (chromic chloride); selenium (selenious acid); iodide (sodium iodide) - solution - 5mg; 1mg; 0.5mg; 10mcg; 60mcg; 75mcg - zinc (zinc sulfate) 5mg; copper (cupric sulfate) 1mg; manganese (manganese sulfate) 0.5mg; chromium (chromic chloride) 10mcg; selenium (selenious acid) 60mcg; iodide (sodium iodide) 75mcg - replacement preparations

Canada - English - Health Canada

pharmaceutical partners of canada inc - zinc (zinc sulfate); copper (cupric sulfate); manganese (manganese sulfate); chromium (chromic chloride) - solution - 5mg; 1mg; 0.5mg; 10mcg - zinc (zinc sulfate) 5mg; copper (cupric sulfate) 1mg; manganese (manganese sulfate) 0.5mg; chromium (chromic chloride) 10mcg - replacement preparations

Canada - English - Health Canada

pharmaceutical partners of canada inc - zinc (zinc sulfate); copper (cupric sulfate); manganese (manganese sulfate); chromium (chromic chloride) - solution - 1mg; 0.4mg; 0.1mg; 4mcg - zinc (zinc sulfate) 1mg; copper (cupric sulfate) 0.4mg; manganese (manganese sulfate) 0.1mg; chromium (chromic chloride) 4mcg - replacement preparations

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

dongkook pharmaceutical co. - propofol - emulsion for i/v injection - 10mg/ml

United States - English - NLM (National Library of Medicine)

vitality works, inc. - magnesium phosphate, monobasic, unspecified (unii: w30t5d628q) (magnesium phosphate, monobasic, unspecified - unii:w30t5d628q), chamomile (unii: fgl3685t2x) (chamomile - unii:fgl3685t2x), arnica montana (unii: o80ty208zw) (arnica montana - unii:o80ty208zw), tribasic calcium phosphate (unii: 91d9gv0z28) (calcium cation - unii:2m83c4r6zb), wood creosote (unii: 3jyg22fd73) (wood creosote - unii:3jyg22fd73), rheum officinale root (unii: a47jp5zg9m) (rheum officinale root - unii:a47jp5zg9m) - for the temporary relief of teething pain, soreness and inflammation of gums, restlessness and irritability related to teething. for the temporary relief of teething pain, soreness and inflammation of gums, restlessness and irritability related to teething

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - european house dust mite extract, quantity: 6 sq-hdm; american house dust mite extract, quantity: 6 sq-hdm - tablet - excipient ingredients: gelatin; sodium hydroxide; purified water; mannitol - allergic rhinitis acarizax is indicated for the treatment of house dust mite (hdm) allergic rhinitis not well controlled despite use of symptom relieving medication in adults and adolescents (? 12 years). allergic asthma acarizax is indicated for the treatment of hdm allergic asthma not well controlled by inhaled corticosteroids and associated with hdm allergic rhinitis in adults. patients? asthma status should be carefully evaluated before the initiation of treatment.